基本信息
views: 0
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
My Research
KEYWORDS
cancer, immunology, stem cell biology, epigenetic regulation, leukemia, tumor microenvironment
SUMMARY
Our laboratory focuses on molecular mechanisms of differentiation and transformation of hematopoietic stem cells and progenitors. More specifically, we focus on mechanisms of both lymphoid (T-ALL, B-ALL) and myeloid (AML, CML, CMML) leukemia initiation and progression. Our work has identified and studied a number of novel oncogenes (including NOTCH1), tumor suppressors (including FBXW7, TET2, ASXL1, CYLD, EZH2, UTX, cohesins) and downstream oncogenic signaling pathways. We have used these pathways to design molecularly targeted therapeutic protocols that inhibit the induction or affect the maintenance of each malignancy.
Moreover, our laboratory is studying mechanisms of hematopoietic stem cell differentiation and self-renewal using both genomic and genetic approaches. Current areas of focus for our lab include the impact of DNA methylation in stem cell transformation, mapping of long non-coding RNAs in a number of human tumors, the discovery of RNA-binding proteins that can control transformation in leukemia, understanding the impact of the 3D chromosomal architecture in cancer, the role of stress responses in human malignancy, and in vivo mapping of the tumor microenvironment for acute leukemia.
KEYWORDS
cancer, immunology, stem cell biology, epigenetic regulation, leukemia, tumor microenvironment
SUMMARY
Our laboratory focuses on molecular mechanisms of differentiation and transformation of hematopoietic stem cells and progenitors. More specifically, we focus on mechanisms of both lymphoid (T-ALL, B-ALL) and myeloid (AML, CML, CMML) leukemia initiation and progression. Our work has identified and studied a number of novel oncogenes (including NOTCH1), tumor suppressors (including FBXW7, TET2, ASXL1, CYLD, EZH2, UTX, cohesins) and downstream oncogenic signaling pathways. We have used these pathways to design molecularly targeted therapeutic protocols that inhibit the induction or affect the maintenance of each malignancy.
Moreover, our laboratory is studying mechanisms of hematopoietic stem cell differentiation and self-renewal using both genomic and genetic approaches. Current areas of focus for our lab include the impact of DNA methylation in stem cell transformation, mapping of long non-coding RNAs in a number of human tumors, the discovery of RNA-binding proteins that can control transformation in leukemia, understanding the impact of the 3D chromosomal architecture in cancer, the role of stress responses in human malignancy, and in vivo mapping of the tumor microenvironment for acute leukemia.
Research Interests
Papers共 333 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Trends in immunologyno. 3 (2024): 177-187
Maria Guillamot,Ipsita Subudhi, Varvara Paraskevopoulou, Aleksandr Prystupa,Ikjot Sidhu,Anna Yeaton, Maria Laskou, Carmen Hannemann, Casey Donahoe, Destini Wiseman,Iannis Aifantis,Shruti Naik,
bioRxiv : the preprint server for biology (2024)
Cancer discoveryno. 7 (2023): 1656-1677
Xufeng Chen, Li Qiao,Hua Zhou,Jia Liu,Bettina Nadorp,Audrey Lasry,Zhengxi Sun, Jiangyan Zhang,Michael Cammer,Kun Wang, Zoe Ciantra, Jing You,
Blood cancer discoveryno. 3_Supplement (2023): A10-A10
Blood cancer discoveryno. 3_Supplement (2023): A20-A20
Xufeng Chen,Qiao Lu,Hua Zhou, Jia Liu,Bettina Nadorp,Audrey Lasry,Zhengxi Sun, Baoling Lai,Gergely Rona, Jiangyan Zhang,Michael Cammer,Kun Wang,
Qiao Lu,Xufeng Chen,Hua Zhou,Jia Liu,Bettina Nadorp,Audrey Lasry,Zhengxi Sun, Jiangyan Zhang,Michael Cammer,Kun Wang,Zoe Ciantra, Jia You,
Journal of Immunologyno. 1 (2023): 89.12-89.12
crossref(2023)
crossref(2023)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn